Targeted Interference with Signal Transduction Events

Paperback Engels 2010 9783642068348
€ 149,21
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Samenvatting

This book does nothing less than lay out the state of development of tomorrow’s cancer drugs, directed against growth factors, growth factor receptors and intracellular signaling molecules with kinase activities. The sequencing of the human genome and insights into signaling pathways have contributed to the understanding of cancer etiology and the development of new, improved cancer drugs such as Herceptin and Glivec. The deregulation of pathways due to mutated cancer genes provides the conceptual basis for future progress. Will it be possible to derive more efficient cancer drugs?

Specificaties

ISBN13:9783642068348
Taal:Engels
Bindwijze:paperback
Aantal pagina's:188
Uitgever:Springer Berlin Heidelberg

Lezersrecensies

Wees de eerste die een lezersrecensie schrijft!

Inhoudsopgave

Introduction: The Rationale for the Development of Targeted Drugs in Cancer Therapy.- Identifying Critical Signaling Molecules for the Treatment of Cancer.- Tyrosine Kinase Inhibitors and Cancer Therapy.- Targeting ERBB Receptors in Cancer.- Inhibition of the IGF-I Receptor for Treatment of Cancer. Kinase Inhibitors and Monoclonal Antibodies as Alternative Approaches.- Inhibition of the TGF-? Signaling Pathway in Tumor Cells.- The Mammalian Target of Rapamycin Kinase and Tumor Growth Inhibition.- The Ras Signalling Pathway as a Target in Cancer Therapy.- The Mitogen-Activated Protein Kinase Pathway for Molecular-Targeted Cancer Treatment.- Clinical Relevance of Targeted Interference with Src-Mediated Signal Transduction Events.

Managementboek Top 100

€ 149,21
Levertijd ongeveer 9 werkdagen
Gratis verzonden

Rubrieken

    Personen

      Trefwoorden

        Targeted Interference with Signal Transduction Events